Notice – January 2022

The Vic Department of Health has again advised that measures to support physical distancing, introduced in March 2020, to protect the health of those in MATOD who may be at increased risk during the COVID-19 pandemic, should continue.

“Please be advised that these measures will continue to remain in place for the duration of Victoria’s COVID 19 pandemic response until further notice.”

A copy of the official advice from the DoH can be found here:
Summary of COVID19 Response Pharmacotherapy – Letter to providers, December 2021.

COVID-19 Response

The current COVID-19 pandemic is creating new challenges for healthcare. The pharmacotherapy treatment system has been identified as a priority area. The Victorian Department of Health and Human Services (DHHS) and the Pharmacotherapy Area-Based Networks are providing advice on a range of strategies to ensure continuity of treatment for pharmacotherapy patients and associated supports for prescribers and dispensers.

These strategies include:

  • Lowering the threshold for takeaway doses with reasonable management of risk and benefit
  • Increasing the duration of prescriptions
  • Collection of takeaways and/or stewardship by a responsible third party
  • Roster of pharmacies and prescribers in local areas who are willing and able to deputise services
  • Expanding access to long acting injectable buprenorphine as an alternative to daily Suboxone
  • Prescriber and pharmacy service continuity and contingency planning

This is an evolving situation and this page will be regularly updated.

You local pharmacotherapy network managers are available to assist you. If you have any queries regarding these, or any other pharmacotherapy matter please feel free to contact your local network manager via the details found on our ‘About’ page.